Effective Top Quality Anti-Fibrosis Drug Pirfenidone 53179-13-8 for Health Treatment

Model NO.: 53179-13-8
Name: Pirfenidone
Model No.: 53179-13-8
Standard: 99.9% Min
Package: as Required
Export Markets: Global
Grade: Pharmaceutical Grade
Trademark: Yijng
Transport Package: 25kg/Drum
Specification: 99%
Origin: Shanghai
HS Code: 3801100010
Model NO.: 53179-13-8
Name: Pirfenidone
Model No.: 53179-13-8
Standard: 99.9% Min
Package: as Required
Export Markets: Global
Grade: Pharmaceutical Grade
Trademark: Yijng
Transport Package: 25kg/Drum
Specification: 99%
Origin: Shanghai
HS Code: 3801100010
Effective Drug Pirfenidone 53179-13-8 For Treat Disease Idiopathic Pulmonary Fibrosis


Pirfenidone
CAS: 53179-13-8
Solubility: DMSO: 10 mg/mL, soluble
Appearance: White crystal powder
Melting Point: 102--109
Loss on drying: <1.0%
Known single impurity: <1.0%
Unknown single impurity: <0.5%
Total impurity: <2.0%
Assay(as dried): 99%min


Overview

Pirfenidone (PFD) is a novel kind of pyridine ketones which has a broad-spectrum anti-fibrotic effect, being able to prevent and reverse the formation of fibrosis and scar. It into into market in Shionogi, Japan in 2008 and has been approved by the US drug and Drug Administration. It is the first drug which has gone through phase III clinical trials (including repeating, randomized, and placebo-control) which has its effectiveness in treatment idiopathic pulmonary fibrosis (IPF); moreover, the drug has relative good efficacy in treatment some fibrotic diseases such as renal interstitial fibrosis and liver fibrosis. accident, it is also extensive applied in the phase II clinical study in kidney disease (focal segmental glomerulosclerosis), hypertrophic cardiomyopathy, adult type I neurofibromatosis, of neurofibromatosis and plexiform neurofibromas, diabetes union with kidney disease.


Clinical application

1. Idiopathic pulmonary fibrosis degeneration
Idio-pathic pulmonary fibrosis (idio-pathic pulmonary fibrosis, IPF) is a cause of unknown, poor prognosis, high mortality of chronic inflammatory interstitial lung disease, and PFD is an anti-inflammatory, anti-fibrosis agents, Can be used for the treatment of IPF.
2. liver fibrosis
3. Renal fibrosis
4. Multiple sclerosis
Multiple sclerosis (multiple sclerosis, MS) is associated with central nervous system and immune-related inflammation and demyelinating disease. The associated immune factors are the activation of stellate cells, glial cells, endothelial cells and lymphocytes, whereas PFD has the ability to inhibit cell activation.
5. Myocardial fibrosis
Cardiovascular diseases such as hypertension, cardiomyopathy and atrial fibrillation can lead to fibrosis of the myocardium, and thus the deterioration of the disease or the development of PFD treatment of sexual levator dystrophy caused by cardiomyopathy, can inhibit myocardial fibrosis, improve Heart function. PFD reduces myocardial remodeling and atrial fibrillation by inhibiting fibrosis.
6. Tumor disease: neurofibroma, uterine leiomyoma, malignant glioma.
7. Prevention of fibrosis after organ transplantation
8. Rheumatoid arthritis


Pharmacological effects

PFD is a potent inhibitor of a cytokine by regulating or inhibiting certain factors, thus inhibiting the biological activities of fibroblast cells and reducing the cell proliferation and the synthesis of collagen matrix. Meanwhile, PFD can also inhibit the secretion of inflammatory mediators, reduce lipid peroxidation, and exert its anti-inflammatory and antioxidant effects. 

1. Inhibition of collagen synthesis
Fibroblast growth factor (bFGF), transforming growth factor-β (transforming growth factor-β, TGF-β), connective tissue growth factor (connective tissue growth factor, CTGF) and tissue inhibitor of metalloproteinase 1 (TIMP-1) are growth factors that related with fibrotic diseases. They can promote fibroblast proliferation and growth, increase the synthesis of collagen matrix and prevent the degradation of extracellular matrix (ECM). They are expressed to different extent during the formation of organ fibrosis. PFD can effectively reduce the expression of the proteins such as bFGF, TGF-β, CTGF and TIMP-1 in the fibroblast cells of lung and kidney and be correlated with the reduction of collagen synthesis and matrix.
The formation of I and III type collagen fibers is also closely related to the synthesis of collagen matrix. At the same time of reducing TGF-β expression, PFD can also reduce the generation α I collagen. PFD also inhibit the expression of pulmonary fibrosis I collagen. In addition, PFD also has inhibitory effect on the expression of type III collagen mRNA and can reduce the synthesis of collagen type III.

2. The anti-inflammatory effects
PFD can inhibit to the inflammatory mediators to varying degrees for exerting their anti-inflammatory effects. When the inflammatory cytokines is overexpressed inside the lung, the inflammation reaction is exacerbated, thus making alveolar wall being thickening, reducing the function of pulmonary alveoli, and ultimately causing fibrosis. PFD primarily take anti-inflammatory effects by inhibiting the expression of inflammatory mediators, reducing vascular permeability, and reducing the agglomeration of neutropenia and inflammatory cells, thus further preventing or slowing down the fibrosis of organs and tissues.

3. Anti-oxidation effect
PFD mainly exert their antioxidant effects by scavenging free radicals and inhibiting lipid peroxidation and oxidative stress mitigation.
 
Effective Top Quality Anti-Fibrosis Drug Pirfenidone 53179-13-8 for Health Treatment


Delivery Terms

Delivery Time: Within 12 hours upon receipt of payment;
Shipping time: 3-7 working days (Door-to-Door);
Package pictures: Photos of parcel would be offered;
Tracking number:  Offered once it is delivered;
 
Payment ways: Bank Transfer, Western Union, Money Gram and Bitcoin;
Delivery ways: All Express Modes( EMS, DHL, TNT, FedEx, UPS, TOll etc.);
Packing: Select best ways according to quantity and safety degree( Super discreet, professional and experienced);
 
After-sale service: 24/7 Online for any problems;
Gurantee: Resend the goods if caught by customs.
 
Product name CAS No. Specification
Ostarine(MK2866) 841205-47-8/1235370-13-4/1202044-20-9 99%min
LGD-4033 1165910-22-4 98%min
MK-677 159633-92-8 98%min
Andarine (S-4) 401900-40-17 98%min
GW-501516 317318-70-0 98%min
AICAR 2627-69-2 98%min
RAD140 1182367-47-0 98%min
SR9009 1379686-30-2 98%min
YK11 1370003-76-1
Effective Drug Pirfenidone 53179-13-8 For Treat Disease Idiopathic Pulmonary Fibrosis


Pirfenidone
CAS: 53179-13-8
Solubility: DMSO: 10 mg/mL, soluble
Appearance: White crystal powder
Melting Point: 102--109
Loss on drying: <1.0%
Known single impurity: <1.0%
Unknown single impurity: <0.5%
Total impurity: <2.0%
Assay(as dried): 99%min


Overview

Pirfenidone (PFD) is a novel kind of pyridine ketones which has a broad-spectrum anti-fibrotic effect, being able to prevent and reverse the formation of fibrosis and scar. It into into market in Shionogi, Japan in 2008 and has been approved by the US drug and Drug Administration. It is the first drug which has gone through phase III clinical trials (including repeating, randomized, and placebo-control) which has its effectiveness in treatment idiopathic pulmonary fibrosis (IPF); moreover, the drug has relative good efficacy in treatment some fibrotic diseases such as renal interstitial fibrosis and liver fibrosis. accident, it is also extensive applied in the phase II clinical study in kidney disease (focal segmental glomerulosclerosis), hypertrophic cardiomyopathy, adult type I neurofibromatosis, of neurofibromatosis and plexiform neurofibromas, diabetes union with kidney disease.


Clinical application

1. Idiopathic pulmonary fibrosis degeneration
Idio-pathic pulmonary fibrosis (idio-pathic pulmonary fibrosis, IPF) is a cause of unknown, poor prognosis, high mortality of chronic inflammatory interstitial lung disease, and PFD is an anti-inflammatory, anti-fibrosis agents, Can be used for the treatment of IPF.
2. liver fibrosis
3. Renal fibrosis
4. Multiple sclerosis
Multiple sclerosis (multiple sclerosis, MS) is associated with central nervous system and immune-related inflammation and demyelinating disease. The associated immune factors are the activation of stellate cells, glial cells, endothelial cells and lymphocytes, whereas PFD has the ability to inhibit cell activation.
5. Myocardial fibrosis
Cardiovascular diseases such as hypertension, cardiomyopathy and atrial fibrillation can lead to fibrosis of the myocardium, and thus the deterioration of the disease or the development of PFD treatment of sexual levator dystrophy caused by cardiomyopathy, can inhibit myocardial fibrosis, improve Heart function. PFD reduces myocardial remodeling and atrial fibrillation by inhibiting fibrosis.
6. Tumor disease: neurofibroma, uterine leiomyoma, malignant glioma.
7. Prevention of fibrosis after organ transplantation
8. Rheumatoid arthritis


Pharmacological effects

PFD is a potent inhibitor of a cytokine by regulating or inhibiting certain factors, thus inhibiting the biological activities of fibroblast cells and reducing the cell proliferation and the synthesis of collagen matrix. Meanwhile, PFD can also inhibit the secretion of inflammatory mediators, reduce lipid peroxidation, and exert its anti-inflammatory and antioxidant effects. 

1. Inhibition of collagen synthesis
Fibroblast growth factor (bFGF), transforming growth factor-β (transforming growth factor-β, TGF-β), connective tissue growth factor (connective tissue growth factor, CTGF) and tissue inhibitor of metalloproteinase 1 (TIMP-1) are growth factors that related with fibrotic diseases. They can promote fibroblast proliferation and growth, increase the synthesis of collagen matrix and prevent the degradation of extracellular matrix (ECM). They are expressed to different extent during the formation of organ fibrosis. PFD can effectively reduce the expression of the proteins such as bFGF, TGF-β, CTGF and TIMP-1 in the fibroblast cells of lung and kidney and be correlated with the reduction of collagen synthesis and matrix.
The formation of I and III type collagen fibers is also closely related to the synthesis of collagen matrix. At the same time of reducing TGF-β expression, PFD can also reduce the generation α I collagen. PFD also inhibit the expression of pulmonary fibrosis I collagen. In addition, PFD also has inhibitory effect on the expression of type III collagen mRNA and can reduce the synthesis of collagen type III.

2. The anti-inflammatory effects
PFD can inhibit to the inflammatory mediators to varying degrees for exerting their anti-inflammatory effects. When the inflammatory cytokines is overexpressed inside the lung, the inflammation reaction is exacerbated, thus making alveolar wall being thickening, reducing the function of pulmonary alveoli, and ultimately causing fibrosis. PFD primarily take anti-inflammatory effects by inhibiting the expression of inflammatory mediators, reducing vascular permeability, and reducing the agglomeration of neutropenia and inflammatory cells, thus further preventing or slowing down the fibrosis of organs and tissues.

3. Anti-oxidation effect
PFD mainly exert their antioxidant effects by scavenging free radicals and inhibiting lipid peroxidation and oxidative stress mitigation.
 
Effective Top Quality Anti-Fibrosis Drug Pirfenidone 53179-13-8 for Health Treatment


Delivery Terms

Delivery Time: Within 12 hours upon receipt of payment;
Shipping time: 3-7 working days (Door-to-Door);
Package pictures: Photos of parcel would be offered;
Tracking number:  Offered once it is delivered;
 
Payment ways: Bank Transfer, Western Union, Money Gram and Bitcoin;
Delivery ways: All Express Modes( EMS, DHL, TNT, FedEx, UPS, TOll etc.);
Packing: Select best ways according to quantity and safety degree( Super discreet, professional and experienced);
 
After-sale service: 24/7 Online for any problems;
Gurantee: Resend the goods if caught by customs.
 
Product name CAS No. Specification
Ostarine(MK2866) 841205-47-8/1235370-13-4/1202044-20-9 99%min
LGD-4033 1165910-22-4 98%min
MK-677 159633-92-8 98%min
Andarine (S-4) 401900-40-17 98%min
GW-501516 317318-70-0 98%min
AICAR 2627-69-2 98%min
RAD140 1182367-47-0 98%min
SR9009 1379686-30-2 98%min
YK11 1370003-76-1

If you get slow effects from using Human Growth Hormone or Bodybuilding Peptides alone and want a faster effects,you can try to use anabolic steoids.You must have a question [How can I get the anabolic steoids oils with real dosage and high purity?"Homebrewing steroids oils by your own through buying raws steroids will be the most reliable way to guarantee you get the real dosage and clean stuff.But some people will say [I`m busy and have no time to do it by myself",no worries,buying Semi-Finished Steroids Oils from reliable raws steroids and Sarms Raws source is the best choice if you have no time to homebrew steroids.You just need to filter Semi-finished Steroids Oils,then you can get high purity steroids to use.

First, we have to make it clear that the semi- Finished Steroids oils which we are offering are actually "finished". It means that the oils are produced with our high purity steroid raw powders, BA, BB and carrier oil (GSO, CSO and EO, etc.) already.
We homebrew semi-finished steroids oils as below recipes,listing some of the recipes below are our own formulation or formulations from the Labs that we supply.
Testosterone Enanthate 250mg/ml - 10ml
6.44ml Oil
2.5g Testosterone Enanthate Powder
0.2ml BA (2%)
1ml BB (10%)

Testosterone Propionate 100mg/ml - 10ml
6.89ml Oil
1g Testosterone Popionate Powder
0.2ml BA (2%)
2ml BB (20%)

Trenbolone Acetate 100mg/ml - 10ml
6.95ml Oil
1g Trenbolone Acetate Powder
0.2ml BA (2%)
2ml BB (20%)

Primobolan ( Methenolone Enanthate ) 100mg/ml - 10ml
6.95ml Oil
1g Methenolone Enanthate Powder
0.2ml BA (2%)
2ml BB (20%)

Deca Durabolin ( Nandrolone Decanoate ) 250mg/ml - 10ml
7.24ml Oil
2.5g Nandrolone Decanoate Powder
0.3ml BA (3%)
1.5ml BB (15%)

How to Filter semi-finished steroids oils? 
Filtering is just a simple process to let the semi-finished steroids oils get through the filter membrane.
During this process, since the size of most of the bacteria are larger than 0.6 um, so the pore size of filter membrane 0.22 or 0.45 um will be good, the bacteria will leave behind on the filter membrane and thesemi-finished steroids oilsbecome sterile and safe for injection.
To filter semi-finished steroids oils, according to the quantities, there are mainly 3 types of filters, vacuum pump filter set, bottle top filter set and syringe filters. And the most recommended is bottle top filter set. For most of customers who are producing bulk batches of final products of steroid injectable, vacuum pump filter set,

How to Get the Filtered Oils Into Sterile Vials?
For those who want to start their own business by producing steroids by themselves, this might help.
To produce finished steroid products, the device for getting those filtered oils into vials will be required. There is a very popular device - the dispenser. It will help to get your liters of oil conversions into 10 ml vials. Dispenser will be operated manually.
On the other hand, the peristaltic pump will also work, but it's automatically, your life will be easier with peristaltic pump.

How to Make Stoppers and Vials Sterile?
Sterilization of vials and stoppers:
#1. Clean your vials:
a. Wash with soap and distilled water, rinsing with distilled water;
b. Rinse a second time with an alcohol of your choosing. Isopropyl is also a good choice. Acetone is also acceptable.
#2. Dry and Heat your vials:
a. Place them upside down on a baking sheet that has been properly wiped with an antiseptic;
b. Preheat oven to 350*. Place vials in oven and let set for about 30 mins, allow the vials to cool to room temp and then repeat the process.
#3. Soak stoppers in a hydrogen peroxide solution for a minimum of 10 mins.


Semi-finished Steroids Oils

Semi-finished Steroids Oils

Semi-Finished Steroids Oils,Tren Steroid,Test Enanthate,Boldenone Steroid

beststeroidraws Co., Ltd , http://www.beststeroidraws.com